IMMUNO VACCINE INC Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

Latest Posts

About This Stock More About This Stock
Biotech Stock Immunovaccine At All-Time High, Breaking Out
Article By: Taki Tsaklanos
Friday, April 28, 2017 4:47 PM EST
We wrote in February that stocks in momentum typically run out of steam after some weeks or even days. Immunovaccine went 20% higher after that call, retraced till $1.00, and rallied sharply higher to touch all-time highs at $1.50 per share today.
In this article: IMMVF
Read
Immunovaccine: Biotech Stock With Very Strong Bullish Momentum
Article By: Taki Tsaklanos
Sunday, February 12, 2017 2:25 AM EST
Immunovaccine's volume is currently very high compared to previous levels, so it will be crucial to see how much additional buying interest the company will get from other market participants.
In this article: IMMVF
Read
Chairman Interview: Albert Scardino Of Immunovaccine Inc.
Article By: Peter Epstein
Monday, June 29, 2015 2:45 PM EST
This microcap is developing vaccines for cancer and infectious disease. Their lead product, a vaccine known as DPX Survivac, creates immune cells that attack more than 20 different kinds of cancer.
In this article: IMMVF
Read

PARTNER HEADLINES

Latest Tweets for $IMMVF

No tweets yet!